8,517 articles
Melvin M. Grumbach
Melvin M. Grumbach (1925–2016) was an American pediatric endocrinologist who chaired pediatrics at UCSF, made it a top world program, and pioneered growth hormone treatment for short stature.
Melvin M. Scheinman
Melvin M. Scheinman is an American cardiologist and cardiac electrophysiologist, Professor Emeritus at UCSF, who performed the first catheter ablation in humans in 1981 and helped found cardiac electrophysiology.
Melvin P. Osborne
Melvin P. Osborne was an American surgeon and surgical scientist who worked at Boston City Hospital's Harvard teaching services, researching gastric secretion and hypersecretion after massive bowel resection.
Melvin Spigelman
Melvin Spigelman is a physician and tuberculosis drug-development researcher who serves as President and CEO of the TB Alliance, which developed pretomanid, approved by the FDA in 2019.
Melvyn F. Greaves
Melvyn F. Greaves, born 1941, is a British cancer biologist at London's Institute of Cancer Research known for classifying leukemias and showing childhood ALL starts before birth.
Menna R. Clatworthy
Menna R. Clatworthy is a British nephrologist and clinician scientist who has been Professor of Translational Immunology at the University of Cambridge since 2019, directing CITIID and studying tissue immunity.
Menno V. Huisman
Menno V. Huisman, born 1956, is a Dutch internist and professor emeritus at Leiden University Medical Center, known for the YEARS algorithm and Hestia rule for pulmonary embolism.
Mercedes Pascual
Mercedes Pascual is a Uruguayan theoretical ecologist at New York University who models infectious diseases, known for linking cholera to El Niño and winning the 2014 MacArthur Award.
Meredith M. Regan
Meredith M. Regan is a biostatistician and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School who leads the International Breast Cancer Study Group's statistical center.
Merit Cudkowicz
Merit E. Cudkowicz is an American neurologist who leads ALS research at Massachusetts General Hospital, where she is Chief of Neurology and directs the HEALEY ALS Platform Trial.
Merle A. Sande
Merle A. Sande (1939–2007) was an American infectious-diseases physician-researcher who led San Francisco General Hospital's early AIDS response, co-developed universal precautions, and built HIV treatment capacity in Uganda.
Mervyn Singer
Mervyn Singer is a British intensive care physician, Professor of Intensive Care Medicine at University College London, known for the Sepsis-3 definitions and for inventing the esophageal Doppler monitor.
Mervyn Susser
Mervyn Susser (1921–2014) was a South African-born epidemiologist at Columbia University known for linking disease to social conditions and for Dutch Hunger Winter famine studies.
Meryam Sugulle
Meryam Sugulle is a Norwegian physician-scientist, Professor II in obstetrics and gynecology at the University of Oslo and a consultant obstetrician at Oslo University Hospital, Ullevål.
Meta Roestenberg
Meta Roestenberg is a Dutch infectious-diseases physician and professor of vaccinology at Leiden University Medical Center, known for controlled human infection models for malaria and vaccine testing.
Mette Kalager
Mette Kalager is a Norwegian physician and researcher known for work on cancer screening and overdiagnosis, whose 2010 study found mammography explained only a third of Norway's breast-cancer mortality decline.
Michael A. Caligiuri
Michael A. Caligiuri is an American medical oncologist known for research on interleukin-15 and natural killer cells, and a professor at City of Hope since 2023.
Michael A. Gerber
Michael A. Gerber (born 1939, Kassel) was a German-born American pathologist who studied hepatitis B in liver cells and chaired Pathology at Tulane from 1987 to 1997.
Michael A. Gimbrone
Michael A. Gimbrone Jr., born 1943 in Buffalo, New York, is an American vascular biologist and Harvard pathologist who identified the adhesion molecules E-selectin and VCAM-1, recruited by inflamed arteries in atherosclerosis.
Michael A. Kamm
Michael A. Kamm is an Australian gastroenterologist, Professorial Fellow at the University of Melbourne and Gut Research Group leader at St Vincent's Hospital, specializing in inflammatory bowel disease.
Michael A. Matthay
Michael A. Matthay is an American pulmonary and critical care physician-researcher at UCSF since 1979, known for lung injury research and leading national ARDS clinical trials, including the landmark lower-tidal-volume ventilation trial.
Michael A. Moskowitz
Michael A. Moskowitz is an American physician-scientist and professor of neurology at Harvard Medical School and Massachusetts General Hospital, known for discovering the trigeminovascular system behind migraine pain.
Michael A. Postow
Michael A. Postow is an American medical oncologist, Chief of the Melanoma Service at Memorial Sloan Kettering Cancer Center, known for leading the first randomized trial of nivolumab plus ipilimumab.
Michael A. Weber
Michael A. Weber is an American cardiologist and hypertension specialist, professor and associate dean at SUNY Downstate in Brooklyn, and a pioneer of ambulatory blood pressure monitoring.
Michael Andreeff
Michael Andreeff is a physician-scientist in hematology and oncology who studies how leukemia cells evade programmed cell death, and is Professor of Medicine in the Department of Leukemia at MD Anderson Cancer Center in Texas.
Michael Angelo
Michael Angelo is an American board-certified pathologist and associate professor of pathology at Stanford University School of Medicine, known for developing the MIBI-TOF multiplexed tissue imaging platform.
Michael B. Atkins
Michael B. Atkins is an American medical oncologist treating melanoma and kidney cancer, deputy director of Georgetown Lombardi Comprehensive Cancer Center and a leader in cancer immunotherapy.
Michael B. Kastan
Michael B. Kastan is an American cancer biologist who defined the DNA damage response pathway and its p53 and ATM signaling, and led the Duke Cancer Institute.
Michael Baum (surgeon)
Michael Baum (born 1937) is a British breast surgeon and emeritus professor of surgery at University College London, known for the tamoxifen trials and pioneering single-dose targeted intraoperative radiotherapy.
Michael Boeckh
Michael Boeckh is a German-trained physician-scientist in Seattle who leads viral infection research at Fred Hutch and the University of Washington, focusing on cytomegalovirus in transplant recipients.